U.S. Food And Drug Administration (FDA)

Benefits of self-administered DMPA injections, an analysis of prophylactic pain management in medication abortion care, a need for ongoing education for providers on clinical indications for pelvic exams, the potential use of mifepristone as emergency contraception, and more.

An analysis of the use of verbal anesthesia vs. oral tramadol for pain management in IUD placement, potential effectiveness of DMPA as a self-bridging emergency contraceptive, the importance of access to PrEP among people at risk of HIV infection through receptive vaginal intercourse, and more.

IUD use and a demonstrated decreased risk of ovarian cancer, salpingectomy vs. tubal ligation for sterilization, benefits of non-medical treatment options for recurrent bacterial vaginosis, and more.

Guidance for providers on medication abortion provision up to 70 days gestation, the need for expanded access to the most effective forms of emergency contraception, the important role partner treatment can play in the treatment of bacterial vaginosis, and more.

Society of Family Planning’s clinical recommendations for contraceptive counseling for transgender and gender-expansive patients, the positive effect of levonorgestrel IUDs on female sexual function, barriers to abortion care within religious hospital systems, and more.

An analysis of the benefits and risks of immediate postpartum IUD insertion, demonstrated improved health outcomes for society as a whole with universal access to contraception, a systematic review of studies of the efficacy and safety of extended IUD use, and more.

Each ANNOVERA can be used for up to a year, no refrigeration needed.

What you need to know about the current research and how to talk to patients.